We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.02 | -0.92% | 2.16 | 2.12 | 2.20 | 2.20 | 2.13 | 2.20 | 733,951 | 16:35:21 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Finance Services | 0 | -3.81M | -0.0114 | -1.87 | 7.1M |
From Apr 2019 to Apr 2024
TIDMIMM
RNS Number : 6736O
Immupharma PLC
29 May 2015
FOR IMMEDIATE RELEASE 29 MAY 2015
ANNUAL GENERAL MEETING: 2015
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed. A summary of proxy votes is shown in the table below. Please also refer to the 'Notice of the 2015 Annual General Meeting' in the Report & Accounts - 31 December 2014 (page 55).
Hot Features
Premium
RESOLUTION FOR + % AGAINST % WITHHELD
DISCRETION
------------- ------------ ------ ---------- ----- ---------
1 37,051,623 91.52 3,432,424 8.48 300
------------- ------------ ------ ---------- ----- ---------
2 40,327,447 99.61 156,900 0.39 0
------------- ------------ ------ ---------- ----- ---------
3 40,327,447 99.61 156,900 0.39 0
------------- ------------ ------ ---------- ----- ---------
4 40,443,946 99.90 40,000 0.10 0
------------- ------------ ------ ---------- ----- ---------
5 40,441,085 99.90 41,800 0.10 1,462
------------- ------------ ------ ---------- ----- ---------
6 (Special
Resolution) 40,323,858 99.61 159,762 0.39 727
------------- ------------ ------ ---------- ----- ---------
For further information please see the Group's web site, www.immupharma.org, or contact:
END
For further information please contact:
+ 44 (0) 20 7152
ImmuPharma plc 4080
Dimitri Dimitriou, Chief Executive
Officer
Dr Robert Zimmer, President
and Chief Scientific Officer
Lisa Baderoon, Head of Investor
Relations + 44 (0) 7721 413496
Panmure, Gordon & Co., NOMAD
& Broker +44 (0) 20 7886 2500
Hugh Morgan
Fred Walsh
Duncan Monteith
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGDMGZKMLLGKZM
1 Year Immupharma Chart |
1 Month Immupharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
